Structure Therapeutics Inc.
GPCR· Nasdaq
Released Aug 6, 2025, after the close
10-Q filed Aug 6, 2025, 37 days after period end · 0001558370-25-010541
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$61.66M | -$26.03M | -$23.28M | -$13.95M |
| EPS Diluted | -$0.36 | -$0.18 | -$0.20 | -$1.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Structure Therapeutics Inc. · CIK 1888886 · Engraved from SEC EDGAR